baber/WOPTO huggingface dataset:
Patent NZ-205485-A (NZ)
Title: Substituted azolylether-ketones and -carbinols and fungicidal compositions
Inventor: JAGER G
IPC: C07D405/06
Filed: 1983-09-05
Abstract: 1. Substituted azolylether-ketones and -carbinols of the formula  see diagramm : EP0102591,P33,F1  in which Ar represents phenyl which is optionally monosubstituted or polysubstituted by identical or different substituents, the following being mentioned as substituents : halogen, alkyl having 1 to 4 carbon atoms, alkoxy and alkylthio, each having 1 to 2 carbon atoms ; halogenoalkyl, halogenoalkoxy and halogenoalkylthio, each having 1 to 2 carbon atoms and 1 to 5 identical or different halogenatoms, alkoxycarbonyl having 1 to 4 carbon atoms in the alkyl part, nitro, cyano or phenoxy or phenyl which is optionally substituted by halogen and/or alkyl having 1 to 2 carbon atoms, Az represents 1,2,4-triazol-1-yl, 1,2,4-triazol-4-yl or imidazol-1-yl, B represents the keto group or a CH(OH) grouping and R represents cycloalkyl which has 3 to 7 carbon atoms and is monosubstituted or polysubstituted by identical or different substituents, the following being mentioned as substituents : halogen, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 2 carbon atoms and phenyl ; and furthermore represents the groupings -C(CH3 )2 -R**1, -C(CH3 )2 -CH2 CH2 -R**2, -C(CH3 )2 -(CH2 )m -R**3 and -C(CH3 )2 -(CH2 )n -R**4 ; wherein R**1 represents straight-chain or branched alkyl having 2 to 6 carbon atoms, alkenyl having 3 to 6 carbon atoms and alkinyl having 2 to 4 carbon atoms, and also represents the aldehyde group and its derivatives, such as oximes, oxime-ethers and acetals, such as dialkyl acetals having 1 to 4 carbon atoms in each alkyl part, or represents dioxane and dioxolane, R**2 represents phenoxy which is optionally monosubstituted or polysubstituted by identical or different substituents, suitable substituents being the phenyl substituents mentioned above in the case of Ar ; R**3 represents phenyl which is optionally monosubstituted or polysubstituted by identical or different substituents, suitable substituents being the phenyl substituents mentioned above in the case of Ar ; R**4 represents fluorine, chlorine or bromine ; m represents integers from 1 to 4 and n represents integers from 2 to 4, and their acid addition salts and metal salt complexes.
Patent NZ-229227-A (NZ)
Title: Process for production of paper characterised by the addition of an aluminium compound, a cationic retention agent and a polymeric silicic acid to the pulp before dewatering
Inventor: JOHANSSON HANS ERIK
IPC: D21H23/04
Filed: 1989-05-22
Abstract: A process for the production of paper by forming and dewatering a suspension of cellulose containing fibres, and optional fillers, on a wire. The forming and dewatering is carried out in the presence of a combination of an aluminum compound, a cationic retention agent and a polymeric silicic acid having a high specific surface area. The combination of substances improves dewatering and retention of fines and fillers.
Patent NZ-232201-A (NZ)
Title: Expression vector system for the production of chimeric monoclonal antibodies
Inventor: ZERLER BRADLEY R
IPC: C07K16/24
Filed: 1990-01-23
Abstract: The present invention relates to an expression system for producing chimeric antibodies. The expression system includes vectors that contains the entire human genomic constant region of a immunoglobulin heavy and/or light chain and is adaptable for insertion, without mutagenesis, of a nonhuman antibody variable region. The resulting expression vector incyludes the entire human genomic constant region and the entire nonhuman variable region lacking tissue specific promoter and/or enhancer regions normally associated with genomic DNA. Chimeric monoclonal antibodies to interleukin-2 receptor and tumor neucrosis factor are examples of chimeric monoclonal antibodies that can be produced by this method.
Patent NZ-235529-A (NZ)
Title: Azetidinone derivatives and their preparation
Inventor: GATEAU-OLESKER ALICE
IPC: C07H19/04
Filed: 1990-10-01
Abstract: Compounds of formula I, consisting of the combination of formulae IA and IB: <IMAGE>  in which:   R1 denotes a hydrogen atom, a halogen atom, an alkyl radical, a trifluoromethyl radical, an alkoxy radical, a phenyl or benzyl radical (which are optionally substituted), a benzyloxy radical, a cyano radical, an alkoxycarbonyl radical, a carboxyl radical or an alkylamino radical, R2, different from R1, denotes a hydrogen atom, a halogen atom, an alkyl radical, a trifluoromethyl radical, an alkoxy radical, a phenyl or benzyl radical (which are optionally substituted), a benzyloxy radical, a cyano radical, an alkoxycarbonyl radical, a carboxyl radical or an alkylamino radical, each R3 denotes an alkyl radical or the two R3s form together and with the atoms of the dithioacetal functional group to which they are attached a 5- to 7-membered ring, R4 denotes an optionally substituted phenyl radical, a naphthyl radical or a furyl radical, each of R5 and R6, which are identical or different, denotes a hydrogen atom, an alkyl radical or an aryl radical (optionally substituted), and each R7 denotes a methyl radical or the two R7s form together and with the carbon atom to which they are attached a cyclohexane nucleus or a cyclopentane nucleus.   The compounds of formula IA and IB are intermediates which are useful for the preparation of compounds of formulae XA and XB: Original abstract incomplete.
Patent NZ-245796-A (NZ)
Title: Prefilled plastics syringe with one-way valve and end cap restraining device
Inventor: LIEBERT RICHARD T
IPC: A61J3/00
Filed: 1993-01-29
Abstract: A pre-filled plastic syringe (10), container or vial containing a liquid product for terminal sterilization comprising: a barrel (20) equipped with a one-way valve (30) and a slidable plunger (50) to equalize pressure differentials; an optional filter (40) engaging the one way valve to prevent backward migration of viruses and bacteria; an end cap (60) covering the open end (26) of the barrel to maintain sterility; and an end cap restraining device (80) to prevent plunger blow-out is described. <IMAGE>
Patent NZ-247257-A (NZ)
Title: Composition comprising a 3beta-alkanoyloxy-6-ethyl-3abeta-methyldecahydro-7h-benz-(e)i nden-7-one (inocoterone ester)
Inventor: KIM KWON H
IPC: A61P17/00
Filed: 1993-03-26
Abstract: Novel compositions comprising an antiandrogenic compound of the formula <CHEM> wherein R is COR1 wherein R1 is loweralkyl and a vehicle comprising a metabolism modulator and a polar organic solvent, are disclosed.
Patent NZ-248360-A (NZ)
Title: Substituted 2-saccharinylmethyl aryl carboxylate derivatives and medicaments
Inventor: DUNLAP RICHARD PAUL
IPC: C07D417/04
Filed: 1993-08-09
Abstract: Novel 4-R<4>-R<5>-2-Saccharinylmethyl aryl carboxylates of formula I   <CHEM> prepared by reacting a 4-R<4>-R<5>-2-halomethylsaccharin with an arylcarboxylic acid in the presence of an acid-acceptor, compositions thereof and their use in the treatment of degenerative diseases are described.
Patent NZ-258144-A (NZ)
Title: 3'-heteroaryl substituted taxane derivatives and their preparation; pharmaceutical compositions
Inventor: BOUCHARD HERVE
IPC: A61K31/337
Filed: 1993-11-22
Abstract: PCT No. PCT/FR93/01145 Sec. 371 Date May 23, 1995 Sec. 102(e) Date May 23, 1995 PCT Filed Nov. 22, 1993 PCT Pub. No. WO94/12484 PCT Pub. Date Jun. 9, 1994This invention relates to a method for the preparation of taxane derivatives having the formula (I) and pharmaceutical compositions which contain the derivatives thus obtained. In formula (I), R is hydrogen or acetyl, R1 is benzoyl or R2-O-CO wherein R2 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl and Het is a 5-membered optionally substituted aromatic heterocycle (thiophene, tiazole, furan, pyrrole, imidazole, oxazole, isoxazole, pyrazole). The products of formula (I) have remarkable antitumor and antileukemia properties.    <IMAGE>  (I)
Patent NZ-259472-A (NZ)
Title: Rubbish bin partition: includes a sleeve that fits into bottom of the bin and a dividing panel that is engaged with the sleeve
Inventor: RIPAMONTI MARIO BENITO
IPC: B65F1/00
Filed: 1994-01-05
Abstract: PCT No. PCT/AU94/00007 Sec. 371 Date Jan. 19, 1996 Sec. 102(e) Date Jan. 19, 1996 PCT Filed Jan. 5, 1994 PCT Pub. No. WO95/03238 PCT Pub. Date Feb. 2, 1995An insert assembly for a bin, the insert comprising a sleeve (10) which is insertable into the bin sad which can be positioned adjacent a bottom wall of the bin, the sleeve (10) including a first engaging means (12A, 12B); a bin dividing panel (11) insertable into the bin to divide the bin into a plurality of separate zones, the panel (11) being extendible from adjacent the bottom wall of the bin and being engageable with the first engaging means (12A, 12B) to prevent sideways movement of the panel in at least one direction in the bin; second engaging means (13A, 13B) in use being adjacent the mouth of the bin to hold the panel (11) against sideways movement in at least one direction, and, means (20A-21A, 20B-21B) to prevent the panel (11) from being removed from the bin upon emptying of the bin.
Patent NZ-280982-A (NZ)
Title: Antimicrobial composition having low voc (volatile organic compound) comprising a microemulsion (concentrate) of 2-n-octyl-3-isothiazolone and surfactant mixture of ethoxylated oil non-ionic surfactant and sulphated or sulphonated oil anionic surfactant
Inventor: YU BING
IPC: A01N43/80
Filed: 1996-02-14
Abstract: A composition essentially free of organic solvents and having low VOC comprising (A) 2-n-octyl-3-isothiazolone as microbicidally active ingredient, (B) a surfactant system comprising (B1) an ethoxylated oil non-ionic surfactant and (B2) a sulfated or sulfonated oil anionic surfactant, the weight ratio of A:B being ≤ 50:50 and the weight ratio of B1:B2 being 20:80 to 70:30, optionally including 0 to 99.99% by weight water, said composition being in the form of a microemulsion concentrate or a microemulsion, said (A) being stable, and a method of protecting a locus using said composition.
Patent NZ-304235-A (NZ)
Title: Method for detecting microorganisms
Inventor: VESEY GRAHAM
IPC: G01N33/569
Filed: 1996-04-03
Abstract: ethods for detecting microorganisms in a sample by binding detectable particles and fluorescent labelled ligands reactive to the microorganisms. The disclosure also includes the use of multiple fluorochromes for the detection of microorganisms and is adaptable for use in flow cytometry.
Patent NZ-305152-A (NZ)
Title: Package partition delivery; details of system for stacking and delivering partitions for bottle/can packages
Inventor: MONCRIEF FRANK
IPC: B65H1/02
Filed: 1996-03-13
Abstract: A partition feeder has a multi-rack assembly for holding more than one reserve stack of partitions. The partition feeder has a main stack of partitions which is forced against a set of tabs and which has its partitions removed by a selecting apparatus. When the main stack has been reduced down past a certain amount, one of the reserve stacks is automatically moved into alignment with the main stack and the partitions in the reserve stack are added to the main stack. The partition feeder has guide rails that are received in notched sides of the partitions, thereby suspending the partitions on the guide rails. An inner frame, upon which the guide rails are mounted, is adjustably mounted to a middle frame to thereby permit the adjustment of the distance between the guide rails. The middle frame is adjustably mounted to an outer frame to permit the vertical adjustment of the mass feeder. The partition feeder can therefore be easily adjusted for partitions of different sizes.
Patent NZ-328455-A (NZ)
Title: Packaging machine for packaging bottles/cans into preformed cartons comprising a carton conveyor, an article infeed conveyor and a carton sealing compression assembly unit comprising endless belts on opposite sides biased against cartons to accommodate variations in carton width
Inventor: MONCRIEF FRANK
IPC: B65G15/20
Filed: 1997-03-25
Abstract: An article packaging machine 11 comprises a frame, carton conveyor means mounted to the frame defining a carton path, an infeed conveyor assembly on one side of the carton path having an infeed end and a discharge end, a compression assembly  mounted adjacent the discharge end, and means for yieldably biasing flights of first and second moving endless belts 26, 27 of the compression assembly toward each other substantially along the entire lengths of the flights for accommodating carton-to-carton variances in the distance between opposed ends of the cartons as the cartons move between the flights.  The compression assembly maintains the cartons along a fixed centreline as the cartons travel the lengths of the flights along the carton path.  Each flight of the endless belts has a front surface facing the carton path and a back surface opposite the front surface.  The means for yieldably biasing the flights comprises a first upstanding bracket 32 having a first upstanding backer plate 34 positioned to bear against the back surface of one of the flights and a second bracket having a second upstanding backer plate positioned to bear against the back surface of the other end of the flights.  Linear bearings 36 movably mount the brackets to the frame for relative movement towards and away from each other.  Biasing means 38 yieldably bias the brackets towards each other.  An alignment rib on the back surface of each flight and a corresponding aligned groove extend along each of the backer plates, the ribs riding in the grooves to maintain the flights in vertical alignment.
Patent NZ-329545-A (NZ)
Title: Absorbent product, barrier device projects from each laterally extending positioning tab
Inventor: BOULANGER ROGER
IPC: A61F13/15
Filed: 1998-01-06
Abstract: A sanitary absorbent article is provided which has a generally rectangular main body (2) and two positioning tabs (3) laterally extending from the main body (2) for use in securing the article to an undergarment (26) of a user. The tabs (3), when folded, provide upstanding barriers (20) that extend along the longitudinal edges of the main body (2) to prevent leakage of menstrual fluid. <IMAGE>
Patent NZ-332829-A (NZ)
Title: Use of a polypeptide corresponding to a serine threonine kinase receptor, ALK-7 for neurological diseases
Inventor: IBANEZ CARLOS FERNANDO
IPC: A61K38/17
Filed: 1995-10-20
Abstract: Use of a polypeptide comprising an amino acid sequence corresponding to a serine threonine kinase receptor, ALK-7, in the preparation of a medicament for the treatment of neurological disease in a mammal, like Alzheimer's disease.
Patent NZ-505398-A (NZ)
Title: Window or door frame element having formation for retaining a building panel
Inventor: DE BONO ARTHUR
IPC: E06B1/34
Filed: 1998-12-18
Abstract: A frame element (3) for use in a window or door frame, the frame element including: a longitudinal frame portion (14) and a longitudinal retaining formation (6, 8) associated therewith, the retaining formation (6, 8) being configured to retain a longitudinal edge (15) of a generally planar building panel (2) such that the edge (15) is disposed between the lateral edges (26, 27) of the frame portion (14) wherein the building panel forms a surround adjacent the frame element (3) when installed.
Patent NZ-510587-A (NZ)
Title: 4-aminopyrrolopyrimidines as kinase inhibitors
Inventor: ARNOLD LEE D
IPC: A61P15/00
Filed: 1999-09-17
Abstract: Protein kinase inhibitor compounds of the shown formula, and their use in medical treatment of conditions mediated by protein kinase activity.
Patent NZ-511863-A (NZ)
Title: Semi-hydrochloride or 8-cyano-1-cyclopropyl -7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Inventor: HIMMLER THOMAS
IPC: A61P31/04
Filed: 1999-11-15
Abstract: The invention relates to a semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1S, 6S-2,8- iazabicyclo [4.3.0]nonan -8-yl)-6- fluoro- 1,4 -dihydro- 4-oxo-3-quinoline carboxylic acid, to a method for producing this, and to an antibacterial agent containing the same.
Patent NZ-521734-A (NZ)
Title: Diazabicyclic central nervous system active agents
Inventor: SCHRIMPF MICHAEL R
IPC: A61P25/00
Filed: 2001-04-27
Abstract: Disclosed herein are N-substituted diazabicyclic compounds of formula (I) and pharmaceutical compositions thereof that are suitable for controlling synaptic transmission in mammals (nicotinic acetylcholine receptor ligands), wherein A, B, R1, R9, Y and Z are as defined in the specification. A method for selectively controlling neurotransmitter release in mammals using these compounds for controlling pain in mammals is also described.
Patent NZ-525105-A (NZ)
Title: Treatment of breast cancer with a combination of an antioestrogen and a sex steroid inhibitor so there is minimal material interference with the absorption, distribution, metabolism and excretion (ADME)
Inventor: MORAN S MARK
IPC: A61K31/00
Filed: 2001-10-03
Abstract: Methods are provided, which increase the effectiveness of a combination drug therapies for treating oestrogen-sensitive diseases, such as breast cancer, as well as the combinations and kits used to treat such diseases.
Patent NZ-535529-A (NZ)
Title: Electronic transfer systemusing a single use transaction identification number
Inventor: ONG YONG KIN MICHAEL
IPC: G06Q20/02
Filed: 2003-02-28
Abstract: A method of conducting an on-line transaction includes providing a transaction manager 12. A single use transaction request identification is generated using a user provided code. The transaction manager relates the transaction request identification to banking information of a registered user. The registered user is provided with the transaction request identification and requests to purchase a product or service having a value from a merchant. The purchase request includes providing the transaction request identification to the merchant. The merchant sends a payment request to the transaction manager for a fund transfer of the value from the user to the merchant. The payment request includes the transaction request identification and the value. The transaction manager checks the validity of the transaction request identification and disabling re-use of the transaction request identification. If the transaction request identification is valid, the transaction manager sends an EFT request to a financial institution to transfer the value in funds from the user to the merchant. The EFT request includes the banking information. The financial institution checks whether there is sufficient funds are present in user's bank account and if sufficient funds are present performs the transfer according to the banking information. The transaction manager receives confirmation of the transfer from the financial institution and sends the confirmation to the merchant.
Patent NZ-536365-A (NZ)
Title: Controlled evacuation ostomy device with external seal
Inventor: CLINE JOHN B
IPC: A61F5/448
Filed: 2003-03-07
Abstract: An ostomy device consisting of a thin flexible membrane 14 situated within a member B is described. The interior of the member can be pressurized by external hand pump 38 to press the membrane against a stoma to seal it and prevent the discharge of solid and semi-solid waste. Gas escapes through a vent 42 with a filter element. A collection pouch can be provided as part of a device. (62) Divided out of 524606
Patent NZ-542548-A (NZ)
Title: Implantable polymeric device for sustained release of dopamine agonist
Inventor: PATEL RAJESH A
IPC: A61L31/04
Filed: 2004-03-31
Abstract: Disclosed is an implantable device for administration of a dopamine agonist to a mammal in need thereof, comprising a dopamine agonist that binds to one or more dopamine receptor subgroups and a biocompatible, nonerodible polymeric matrix, wherein said dopamine agonist is encapsulated within said matrix, wherein the implantable device is produced by an extrusion process, wherein the implantable device is uncoated, and wherein when said implantable device is implanted subcutaneously in said mammal, said dopamine agonist is continuously released in vivo over a sustained period of time through pores that open to the surface of said matrix at a rate that results in a steady state plasma level of at least about 0.01 ng/ml for the sustained period of time.
Patent NZ-545304-A (NZ)
Title: Novel compounds having inhibitory activity against sodium-dependant transporter
Inventor: NOMURA SUMIHIRO
IPC: A61K31/7072
Filed: 2004-07-30
Abstract: Disclosed is a compound of formula (I) wherein ring A is of formula (i) or formula (ii), ring B is of formula (iii) and wherein the rest of the substituents are disclosed within the specification or a pharmaceutically acceptable salt thereof, or a prodrug thereof.
Patent NZ-547282-A (NZ)
Title: Fil-shaped formulations of desoxypeganine and uses thereof
Inventor: MOORMANN JOACHIM
IPC: A61K9/00
Filed: 2004-11-08
Abstract: Disclosed is an orally administrable film-shaped medicament containing the active substance deoxypeganine and/or a deoxypeganine derivative. The medicament is preferably administered buccally or sublingually and subsequently absorbed via the oral mucosa thereby avoiding first-pass metabolism.
Patent NZ-547539-A (NZ)
Title: An electric switch assembly comprising an arc shield
Inventor: BUDDEN PETER CHARLES
IPC: H01H23/14
Filed: 2005-01-20
Abstract: A dolly assembly for an electric switch is disclosed. The assembly includes at least two parts, where one part includes an outer part (11) and a second part includes an arc shield. The arc shield is positioned substantially inside the first part. The outer part includes a shell that has a top portion, a depending sidewall, and an open bottom. The arc shield extends substantially about an inner wall of the top portion and an inner wall of the sidewall.
Patent NZ-551954-A (NZ)
Title: Carbamate compounds for use in preventing or treating movement disorders
Inventor: PLATA-SALAMAN CARLOS R
IPC: A61P25/28
Filed: 2002-02-21
Abstract: Disclosed is a use of a compound selected from the group consisting of Formula (I) and Formula (II) and enantiomer thereof, wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano) for the preparation of a medicament for the prevention or treatment of movement disorders in a subject in need thereof, wherein the movement disorder is selected from the group consisting of benign essential tremor, tremor in Parkinson's disease, Parkinsonism tremor, other non-related essential tremors, other non-related Parkinsonism tremors, drug-induced tremors and movement disorders, restless leg syndrome, restless arm syndrome, chorea in Huntington's disease, tremors associated with multiple sclerosis or Gilles de La Tourette's syndrome, idiopathic torsion dystonia, focal torsion dystonia, myoclonus and athetosis.. (62) (62) Divided out of 540634
Patent NZ-556275-A (NZ)
Title: Combination of renin and NEP inhibitors for treating diseases mediated by angiotenson II and NEP activity
Inventor: WEBB RANDY LEE
IPC: A61K31/165
Filed: 2006-02-09
Abstract: Disclosed is combination of (a) a renin inhibitor of formula (III) wherein the substituents are as defined in the specification, or a pharmaceutically acceptable salt thereof, (b) a neutral endopeptidase (NEP) inhibitor selected from N-(3-carboxy-1-oxopropyl)-4(S)-p-phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid ethyl ester, or a pharmaceutically acceptable salt thereof or N-(3-carboxy-1-oxopropyl)-(4S)-p-phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid, or a pharmaceutically acceptable salt thereof, and optionally at least one therapeutic agent selected from the group consisting of (c) a diuretic, or a pharmaceutically acceptable salt thereof; and (d) and angiotension II receptor blocker (ARB), or a pharmaceutically acceptable salt thereof.